CCP
CVS icon

Corient Capital Partners’s CVS Health CVS Stock Holding History

Corient Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.34M Hold
25,291
– – 0.18% 113
2022
Q2 		$2.34M Sell
25,291
-911
-3% -$88.9K 0.18% 121
2022
Q1 		$2.65M Buy
26,202
+2,271
+9% +$239K 0.18% 122
2021
Q4 		$2.47M Sell
23,931
-211
-0.9% -$19.5K 0.16% 131
2021
Q3 		$2.05M Buy
24,142
+1,157
+5% +$96.9K 0.15% 133
2021
Q2 		$1.92M Buy
22,985
+1,663
+8% +$136K 0.14% 139
2021
Q1 		$1.6M Sell
21,322
-4,635
-18% -$338K 0.14% 136
2020
Q4 		$1.77M Buy
25,957
+4,750
+22% +$309K 0.18% 118
2020
Q3 		$1.24M Sell
21,207
-1,052
-5% -$65.5K 0.14% 140
2020
Q2 		$1.45M Buy
22,259
+303
+1% +$19.1K 0.18% 117
2020
Q1 		$1.3M Sell
21,956
-4,341
-17% -$290K 0.21% 103
2019
Q4 		$1.95M Sell
26,297
-1,607
-6% -$113K 0.25% 90
2019
Q3 		$1.76M Sell
27,904
-5,209
-16% -$309K 0.25% 90
2019
Q2 		$1.8M Buy
33,113
+2,872
+9% +$155K 0.28% 90
2019
Q1 		$1.63M Sell
30,241
-8,355
-22% -$516K 0.26% 108
2018
Q4 		$2.53M Sell
38,596
-5,669
-13% -$423K 0.45% 44
2018
Q3 		$3.48M Hold
44,265
– – 0.58% 36
2018
Q2 		$2.85M Buy
44,265
+2,410
+6% +$159K 0.5% 57
2018
Q1 		$2.6M Buy
41,855
+605
+1% +$43.4K 0.48% 61
2017
Q4 		$2.99M Buy
41,250
+36,242
+724% +$2.63M 0.51% 53
2017
Q3 		$407K Sell
5,008
-1,159
-19% -$91.7K 0.08% 196
2017
Q2 		$496K Sell
6,167
-109
-2% -$8.61K 0.08% 209
2017
Q1 		$493K Sell
6,276
-383
-6% -$30.6K 0.08% 202
2016
Q4 		$525K Buy
6,659
+306
+5% +$24.8K 0.09% 189
2016
Q3 		$565K Buy
+6,353
New +$600K 0.1% 177

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Corient Capital Partners's CVS Position: Q3 2022 in Review

Corient Capital Partners held its CVS Health (CVS) position steady in Q3 2022 at 25,291 shares worth $2.34M. The position accounts for 0.18% of the portfolio, ranked #113.

Corient Capital Partners first reported a position in CVS in Q3 2016 and has held it in 25 quarters since. The position peaked at $3.48M in Q3 2018. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • Corient Capital Partners held 25,291 shares of CVS Health worth $2.34M as of Q3 2022.
  • Corient Capital Partners left its CVS Health share count unchanged in Q3 2022.
  • CVS Health made up 0.18% of Corient Capital Partners's portfolio in Q3 2022, its #113 holding.
  • Corient Capital Partners first reported a position in CVS Health in Q3 2016 and has held it in 25 quarters since.
  • Corient Capital Partners's CVS Health position peaked at $3.48M in Q3 2018.
  • 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.